Sep 10, 2024 - Update Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders We are pleased to announce three new UK DRI Emerging Leaders: Dr Maura Malpetti, Dr... Learn more Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders
Jan 01, 2024 - Feature Why partner with the UK DRI? The UK DRI is central to a rich and connected dementia research ecosystem, and we... Learn more Why partner with the UK DRI?
Jan 01, 2024 - Feature Why join the UK DRI? By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists... Learn more Why join the UK DRI?
Abstract PMID:24670186 | DOI: UK DRI Authors Dr David Hunt Group Leader Investigating how innate immune activation causes damage to the microvasculature of the brain Dr David Hunt Prof Andrew Jackson Programme Leader at the MRC Human Genetics Unit and honorary consultant in Clinical Genetics Prof Andrew Jackson Prof Siddharthan Chandran Director & CEO Dissecting a genetic cause of ALS and FTD and identifying ways to help protect neurons Prof Siddharthan Chandran
Dr David Hunt Group Leader Investigating how innate immune activation causes damage to the microvasculature of the brain Dr David Hunt
Prof Andrew Jackson Programme Leader at the MRC Human Genetics Unit and honorary consultant in Clinical Genetics Prof Andrew Jackson
Prof Siddharthan Chandran Director & CEO Dissecting a genetic cause of ALS and FTD and identifying ways to help protect neurons Prof Siddharthan Chandran